(Q46898222)

26 December 2017

title

Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease (English)

1 reference

26 December 2017

author name string

Ashraf T

1

1 reference

26 December 2017

Hay JW

2

1 reference

26 December 2017

Pitt B

3

1 reference

26 December 2017

Wittels E

4

1 reference

26 December 2017

Crouse J

5

1 reference

26 December 2017

Davidson M

6

1 reference

26 December 2017

Furberg CD

7

1 reference

26 December 2017

Radican L

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

26 December 2017

American Journal of Cardiology

published in

1 reference

26 December 2017

volume

78

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

409-414

1 reference

26 December 2017

Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Long survival following myocardial infarction. Report on 255 patients living ten years or longer after the first attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Medical costs of coronary artery disease in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Comparison of posthospital survival after acute myocardial infarction in women and men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Prognosis after myocardial infarction: results of 15 year follow up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Ten year mortality in patients with suspected acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Ten-year mortality among patients with suspected acute myocardial infarction in relation to early diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

Five-hundred life-saving interventions and their cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

The role of exercise testing in screening for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900328-1

10.1016/S0002-9149(96)00328-1

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

8752184

1 reference

26 December 2017